Clinical trial

ARB, ACEi, DRi Effects on COVID-19 Course Disease

NCT04364984

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-04-01

PhaseN/A

Study timeline

Study start (actual)2020-04-01Date precision: day

Registry last updated2023-03-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

COVID-19unresolved

Interventions

Angiotensin converting enzyme inhibitorDRUG

Angiotensin Receptor BlockersDRUG

Direct renin inhibitorDRUG

Sponsors & collaborators

Medical Practice Prof D. Ivanovlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04364984 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.